Serotyping and multilocus sequence typing of streptococcus pneumoniae isolates from the blood and posterior nares of Japanese children prior to the introduction of 7-valent pneumococcal conjugate vaccine

Japanese Journal of Infectious Diseases

Volumn 64, Issue 4, 2011, Pages 341-344

  Oishi, Tomohiro ^a,b   Wada, Akihito ^c   Chang, Bin ^c   Toyabe, Shinichi ^a   Uchiyama, Makoto ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b Niigata Prefectural Shibata Hospital   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HOSPITAL ADMISSION; HUMAN; JAPAN; JAPANESE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NOSE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; BACTEREMIA; BLOOD; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HOSPITALS, PEDIATRIC; HUMANS; INFANT; JAPAN; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; NASOPHARYNX; PENICILLIN G; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 79960981847     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. World Health Organization (2007): Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly. Epidemiol. Rec., 82, 93-104.
2. Hicks, L.A., Harrison, L.H., Flannery, B., et al. (2007): Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis., 196, 1346-1354.
3. Pilishvili, T., Lexau, C., Farley, M.M., et al. (2010): Sustained reductions in invasive pneumococcal disease in era of conjugate vaccine. J. Infect. Dis., 201, 32-41.
4. Roche, P.W., Krause, V., Cook, H., et al. (2008): Invasive pneumococcal disease in Australia, 2006. Commun. Dis. Intell., 32, 18-30.
5. Kellner, J.D., Vanderkooi, O.G., MacDonald, J., et al. (2009): Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin. Infect. Dis., 49, 205-212.
6. Hsu, H.E., Shutt, K.A., Moore, M.R., et al. (2009): Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med., 360, 244-256.
7. Lepoutre, A., Varon, E., Georges, S., et al. (2008): Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill., 13(35):pii-18962.
8. Dubos, F., Marechal, I., Husson, M.O., et al. (2007): Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France. Arch. Dis. Child., 92, 1009-1012.
9. Verstrheim, D.F., Løvoll, Ø., Aaberge, I.S., et al. (2008): Effectiveness of a 2 + 1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine, 26, 3277-3281.
10. Rückinger, S., van der Linden, M., Reinert, R.R., et al. (2009): Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine, 27, 4136-4141.
11. Grijalva, C. G, Nuorti, J.P., Arbogast, P. G, et al. (2007): Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet, 369, 1179-1186.
12. Sakata, H. (2005): Study of Streptococcus pneumoniae bacteremia in children. J. Jpn. Assoc. Infect. Dis., 79, 1-6 (in Japanese).
13. Nishimura, T., Fukuzawa, M., Yoshida, H., et al. (2008): Clinical epidemiological study of occult pneumococcal bacteremia in a pediatric outpatient setting. J. Jpn. Pediatr. Soc., 112, 973-980 (in Japanese).
14. Sakata, H. (2005): A study of bacterial meningitis in Hokkaido between 1999 and 2003. J. Jpn. Assoc. Infect. Dis., 79, 680-687 (in Japanese).
15. Chiba, N., Morozumi, M., Sunaoshi, K., et al. (2010): Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol. Infect., 138, 61-68.
16. Sakai, F., Chiba, N., Ono, A., et al. (2010): Molecular epidemiologic characteristics of Streptococcus pneumoniae isolates from children with meningitis in Japan from 2007 through 2009. J. Infect. Chemother. DOI: 10.1007/s10156-010-0180-3.
17. Chang, B., Otsuka, T., Iwaya, A., et al. (2010): Isolation of Streptococcus pneumoniae serotypes 6C and 6D from the nasopharyngeal mucosa of healthy Japanese children. Jpn. J. Infect. Dis., 63, 381-383.
18. Clinical and Laboratory Standards Institute (2008): Performance standards for antimicrobial susceptibility testing; 18th Informational Supplement. Document M100-S18. Clinical and Laboratory Standards Institute, Wayne, Pa., USA.
19. Enright, M.C. and Spratt, B.G. (2008): A mutilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology, 144, 3049-3060.
20. Jacobs, M.R., Good, C.E., Bajaksouzian, S., et al. (2008): Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleaveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin. Infect. Dis., 47, 1388-1395.